Could a $127M Seed Round Change Women's Health Forever? - Dean Remy, Co-Founder @ Mativa Dx

In this episode of Diagnosing Dx, David Filby is joined by Dean Remy, Co-Founder and Chief Commercial Officer at Mativa Dx. Dean brings 35 years of experience across diagnostics, biotechnology, and therapeutics. He explains why pregnancy testing has barely changed in 50 years and how the traditional positive-or-negative result can leave women without critical information during the earliest weeks of pregnancy. Mativa is developing a reusable handheld device combining multiplex biomarker testing, graphene nanosensor technology, an AI-enabled app, and immediate care navigation. The company is also building a large longitudinal maternal biorepository to support future diagnostics, biomarker discovery, and therapeutic development. This is a practical conversation about maternal health innovation, consumer access, partnerships, regulation, data, and building a platform designed to support women throughout the pregnancy journey. Key takeaways: 🔹 Why the traditional pregnancy test does not provide women with enough early information 🔹 How Mativa plans to identify risks such as ectopic pregnancy and pre-eclampsia 🔹 Why a longitudinal maternal biorepository could transform diagnostics and therapeutic development 🔹 How retail, healthcare, pharmaceutical, and diagnostic partnerships could accelerate adoption 🔹 Why supporting the complete patient journey could define the next generation of diagnostics Chapters: 01:08 Introduction and Dean Remy’s background 03:24 Why maternal health urgently needs innovation 06:28 Mativa’s approach and the technology behind the platform 11:42 Building a comprehensive maternal biorepository 14:24 Commercial strategy and market positioning 17:13 Regulatory and reimbursement pathways 20:18 Capital raising and strategic partnerships 25:34 The future of Mativa and maternal diagnostics Guest: Dean Remy Co-Founder and Chief Commercial Officer at Mativa Dx LinkedIn:   / scisourceremy   Learn more about Mativa Dx here: https://www.mativadx.com/ Host: David Filby Founder and CEO of Elevra Consulting LinkedIn:   / davidfilby   🔔 Subscribe to Diagnosing Dx for weekly conversations with leaders shaping the future of diagnostics and omics. #MaternalHealth #WomensHealth #PregnancyCare #Diagnostics #FemTech